Novartis is to buy US biotech IFM Tre in a deal worth up to $1.575 billion, adding a potential drug for the fatty liver disease known as NASH to its pipeline. IFM Tre is a subsidiary of cancer biotech ...
Institut für Mittelstandsforschung (IfM) Bonn Central phone number: 0228/729970 Homepage of the institution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results